Quan Zhang

Dr. Quan Zhang


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2017 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
CDCaifeng Deng
Caifeng Deng
QZQuan Zhang
Quan Zhang
YFYao Fu
Yao Fu
XSXun Sun
Xun Sun
TGTao Gong
Tao Gong
ZZZhirong Zhang
Zhirong Zhang

14 January 2025 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
YWYuhan Wang
Yuhan Wang
JAJunsha An
Junsha An
JZJianbo Zhou
Jianbo Zhou
LCLiming Chang
Liming Chang
QZQuan Zhang
Quan Zhang
FPFu PENG
Fu PENG
Hydroxysafflor yellow A (HSYA), a natural pigment with a chalcone structure extracted from Carthamus tinctorius L. (Safflower), has been widely proven to have good efficacy on cardiovascular diseases, atherosclerosis, cancer, and diabetes. However, no study has reported on the anticancer mechanisms of Hydroxysafflor yellow A (HSYA), a principal bioactive compound in safflower. This review discusses recent developments in the physicochemical properties and sources, pharmacological effects and mechanisms, pharmacokinetic progress, and safety of HSYA, focusing on the involvement of HSYA in the regulation of related pathways and mechanisms of apoptosis, autophagy, and the tumor immune microenvironment in a variety of cancers. This can serve as a theoretical basis for further research and development of HSYA, with insights into the mechanisms of anticancer signaling pathways.

12 December 2016 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
CDCaifeng Deng
Caifeng Deng
MJMengdi Jia
Mengdi Jia
GWGuangfei Wei
Guangfei Wei
TTTiantian Tan
Tiantian Tan
YFYao Fu
Yao Fu
ZZZhirong Zhang
Zhirong Zhang

21 March 2021 in AAPS PharmSciTech
Verified
Journal Article
Closed access
PDF file
JYJing Ye
Jing Ye
SBSha Bao
Sha Bao
SZShiying Zhao
Shiying Zhao
YZYujing Zhu
Yujing Zhu
QRQiao Ren
Qiao Ren
QZQuan Zhang
Quan Zhang

20 April 2018 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
CDCaifeng Deng
Caifeng Deng
XXXiaohong Xu
Xiaohong Xu
DTDrunp Tashi
Drunp Tashi
YWYongmei Wu
Yongmei Wu
BSBingyin Su
Bingyin Su
QZQuan Zhang
Quan Zhang
The safe and efficient targeted delivery of chemotherapeutic drugs has remained a challenge in metastatic breast cancer therapy. Herein, we report a rational drug delivery strategy of co-administering tumor-penetrating peptide-iRGD with self-assembled amphiphilic block copolymer nanoparticles (HA–PLA) to inhibit tumor growth and lung metastasis in 4T1 breast cancer xenograft bearing mice through increasing drug accumulation in the tumors, inducing receptor-mediated tumor cell targeting without causing severe side effects. In vitro, HA–PLA displayed sustained and pH-sensitive release behavior. The cellular uptake of HA–PLA on high CD44-expressing 4T1 cells was significantly higher than the endocytosis on low CD44-expressing L929 fibroblast cells. In vivo, HA–PLA significantly extended the blood circulation time of DOX, displayed no “accelerated blood clearance (ABC) phenomenon” after repeated injection and decreased the side effects of DOX. When combined with iRGD, the drug distribution and penetration of HA–PLA in tumors were remarkably increased, resulting in better antitumor efficacy and the longest whole survival. In particular, the co-administration of iRGD with HA–PLA greatly increased drug distribution in the lung, which contributed to the effective inhibition of the lung metastasis of breast cancer. Therefore, co-administering iRGD with HA–PLA is a promising approach for metastatic breast cancer therapy.

27 December 2022 in Antibiotics
Verified
Journal Article
Open access
PDF file
SLShian Lai
Shian Lai
QZQuan Zhang
Quan Zhang
LJLin Jin
Lin Jin
In recent years, an increasing number of drug-resistant bacterial strains have been identified due to the abuse of antibiotics, which seriously threatens human and animal health. Antimicrobial peptides (AMPs) have become one of the most effective weapons to solve this problem. AMPs have little tendency to induce drug resistance and have outstanding antimicrobial effects. The study of AMPs, especially cyclic peptides, has become a hot topic. Among them, macrocyclic AMPs have received extensive attention. This mini-review discusses the structures and functions of the dominant cyclic natural and synthetic AMPs and provides a little outlook on the future direction of cyclic AMPs.